|
|
|
|
| 20-minute capacity and capabilities quick-looks, 20+ brand new CDMO presenters to evaluate for best-fit this quarter – and a (virtual) commitment of less than 20 percent of your day? We're confident you don’t need 20/20 vision to see the value in this! Join us for Outsourced Pharma's July Partner Week – including sessions in Small Molecule API/HPAPI, Small Molecule Finished Dosage Form, ADC, Analytical Services, and Fill/Finish among others. Registration, on-demand access, and interactive Q&A are free. |
|
|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Chief Editor Louis Garguilo analyzes a report projecting the biologics CDMO secondary packaging market could rise from $2.59 billion this year to USD $5.50 billion by 2034. Projecting so far into the future is tricky business, but Garguilo explains the ultimate value. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
Smart Softgels: Driving Innovation In Pharma | Article | Douglas CDMO | Learn about how softgels are poised to facilitate innovation in the pharmaceutical industry as well as ongoing advancements in optimizing drug bioavailability through nano formulations. |
|
|
|
|
|
|
|
|
Medicinal Chemistry - India | Pharma Expanse | Pharma Expanse supports NCE programs from discovery to commercialization across 9 sites in 5 countries—offering a cost-neutral, innovative business model. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|